137 related articles for article (PubMed ID: 16171148)
1. [Cancer procoagulant (CP)].
Szajda SD; Darewicz B; Gorzel M; Zalewska B; Skrzydlewski Z; Kudelski J; Domel T
Przegl Lek; 2005; 62(3):169-72. PubMed ID: 16171148
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of the efficacy of cancer procoagulant (CP) activity evaluation in the oncological diagnosis of the urinary system].
Szajda SD; Darewicz B; Kudelski J; Werel T; Zwierz K; Skrzydlewski Z; Gabrylewski W
Pol Merkur Lekarski; 2005 Oct; 19(112):596-9. PubMed ID: 16379335
[TBL] [Abstract][Full Text] [Related]
3. Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro.
Kaplinska K; Rozalski M; Krajewska U; Mielicki WP
Thromb Res; 2009 Jul; 124(3):364-7. PubMed ID: 19419757
[TBL] [Abstract][Full Text] [Related]
4. Cancer procoagulant--CP.
Rucińska M; Gacko M; Skrzydlewski Z
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():110-7. PubMed ID: 9337529
[TBL] [Abstract][Full Text] [Related]
5. Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue.
Gordon SG; Mielicki WP
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):73-86. PubMed ID: 9518049
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of detecting cancer procoagulant activity and thyrotropic hormone concentration in the differentiation of tumor-like changes in the thyroid].
Snarska J; Szajda SD; Knaś M; Mroczko B; Borzym-Kluczyk M; Kamiński F; Zwierz P; Zwierz K
Wiad Lek; 2006; 59(5-6):332-5. PubMed ID: 17017477
[TBL] [Abstract][Full Text] [Related]
7. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
[TBL] [Abstract][Full Text] [Related]
8. Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum.
Rucińska M; Furman M; Skrzydlewski Z; Zaremba E
Acta Biochim Pol; 1997; 44(1):109-12. PubMed ID: 9241361
[TBL] [Abstract][Full Text] [Related]
9. [Cancer procoagulant--biochemical characteristics and the influence on the development of neoplastic disease].
Kamocka M; Mielicki WP
Postepy Biochem; 2003; 49(3):168-74. PubMed ID: 15083609
[No Abstract] [Full Text] [Related]
10. [Evaluation of diagnostic values of neoplastic procoagulant in pancreatic, hepatic and ovary cancers].
Snarska J; Szajda S; Skrzydlewski Z; Kozuszko B
Pol Merkur Lekarski; 2003 Aug; 15(86):123-4. PubMed ID: 14648973
[TBL] [Abstract][Full Text] [Related]
11. [Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer].
Szajda SD; Darewicz B; Kudelski J; Chlabicz M; Domel T; Chabielska E; Skrzydlewski Z
Pol Merkur Lekarski; 2005 Jun; 18(108):651-3. PubMed ID: 16124376
[TBL] [Abstract][Full Text] [Related]
12. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.
Dvorak HF; Van DeWater L; Bitzer AM; Dvorak AM; Anderson D; Harvey VS; Bach R; Davis GL; DeWolf W; Carvalho AC
Cancer Res; 1983 Sep; 43(9):4434-42. PubMed ID: 6347372
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a warfarin-sensitive cancer procoagulant in V2 carcinoma.
Roncaglioni MC; Falanga A; D'Alessandro AP; Alessio MG; Casali B; Donati MB
Haematologica; 1989; 74(2):143-7. PubMed ID: 2501168
[TBL] [Abstract][Full Text] [Related]
14. The prothrombotic state in cancer: pathogenic mechanisms.
De Cicco M
Crit Rev Oncol Hematol; 2004 Jun; 50(3):187-96. PubMed ID: 15182825
[TBL] [Abstract][Full Text] [Related]
15. Different expression of procoagulant activity in human cancer cells cultured "in vitro" or in cells isolated from human tumor tissues.
Zucchella M; Pacchiarini L; Tacconi F; Saporiti A; Grignani G
Thromb Haemost; 1993 Apr; 69(4):335-8. PubMed ID: 8497845
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic significance of cancer procoagulant activity in colorectal cancer].
Kozuszko B; Skrzydlewski Z; Famulski W
Pol Merkur Lekarski; 2000 Mar; 8(45):127-8. PubMed ID: 10870414
[TBL] [Abstract][Full Text] [Related]
17. Direct analysis reveals an absence of gamma-carboxyglutamic acid in cancer procoagulant from human tissues.
Kaplinska K; Mielicki WP
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):315-20. PubMed ID: 19448531
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of examination of some tumor markers in diagnostics of liver cancer.
Snarska J; Szajda SD; Puchalski Z; Szmitkowski M; Chabielska E; Kaminski F; Zwierz P; Zwierz K
Hepatogastroenterology; 2006; 53(68):271-4. PubMed ID: 16608038
[TBL] [Abstract][Full Text] [Related]
19. Cancer procoagulant (CP) in lung cancer.
Rucińska M; Skrzydlewski Z; Zaremba E; Furman M; Kasacka I
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():251-3. PubMed ID: 9337542
[TBL] [Abstract][Full Text] [Related]
20. Effect of cancer procoagulant (CP) on the growth and adhesion of MCF-7 cells to vitronectin in vitro.
Kamocka M; Rózalski M; Krajewska U; Wierzbicki R; Mielicki WP
Cancer Lett; 2005 May; 222(1):89-94. PubMed ID: 15837545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
